The present inventions generally relate to implantable devices and, more particularly, to a temporary, electrolytically detachable junction members.
Implants such as vaso-occlusive have been used in various applications including treatment of intra-vascular aneurysms. One known vaso-occlusive device is a soft, helically wound coil. One known coil is formed by winding a platinum wire strand about a primary mandrel and applying heat to the mandrel to impart a primary winding coil shape. The device is then wrapped around a secondary mandrel, and heat is applied to the secondary mandrel to impart a secondary shape. U.S. Pat. No. 4,994,069 to Ritchart et al. and U.S. Pat. No. 5,354,295 to Guglielmi et al., the contents of which are incorporated herein by reference, describe examples of known vaso-occlusive coils and methods of deploying coils to treat aneurysms.
A typical vaso-occlusive coil that may be utilized for occluding peripheral or neural sites is made of 0.05 to 0.15 mm diameter wire (platinum or platinum/tungsten alloy) that is wound so that the primary or linear helical coil shape has an inner diameter of about 0.15 to 1.5 mm with pitch that can be equal to the diameter of the wire used in the coil. The outer diameter of the primary or linear helical shape is typically about 0.25 mm to 1.8 mm. The length of the coil will normally be in the range of 0.5 to 60 cm, e.g., 0.5 to 40 cm.
During use, a delivery catheter or sheath is inserted into a vascular cavity, and the vaso-occlusive coil is delivered or pushed through the delivery catheter in its primary or linear helical shape. The vaso-occlusive coil is deployed from the catheter and delivered to the aneurysm site, after which the coil relaxes from its primary or linear helical shape to assume its secondary, convoluted shape, which facilitates formation of a thrombus. A thrombus reduces blood flow to the aneurysm and limits its growth. After the thrombus is formed, the vaso-occlusive coil is detached or released, and components that were used to delivery the vaso-occlusive coil to the aneurysm are retracted, leaving the coil to occlude the aneurysm.
It is also known to detach vaso-occlusive devices from a delivery or pusher wire using various mechanisms. One known detachment device is a mechanical detachment mechanism. For example, U.S. Pat. No. 5,234,437 to Sepetka describes a method of unscrewing a helically wound coil from a pusher wire having interlocking surfaces, U.S. Pat. No. 5,250,071 to Palermo describes interlocking clasps that are mounted on the pusher wire and the coil, and U.S. Pat. No. 5,261,916 to Engelson describes interlocking ball and keyway-type coupling.
It is also known to use an electrolytically severable joint or temporary connection to release a vaso-occlusive coil at a desired location. For example, U.S. Pat. No. 5,354,295 to Guglielimi describes an embolism forming device and procedure employing an electrolytically severable joint. A platinum coil is delivered to a vascular cavity, such as an aneurysm, using a catheter and a deployment mechanism, such as a pusher or core wire, which has a stainless steel coil or joint attached to the distal end thereof. After the vaso-occlusive coil in its primary shape is placed in the aneurysm, a small electrical current is applied to the core wire to form a clot, which forms a thrombus or collagenous mass that contains the vaso-occlusive device therein. The thrombus or mass fills the aneurysm, thereby preventing the weakened wall of the aneurysm from being exposed to pulsing blood pressure of an open vascular lumen. After the thrombus has been formed, the vaso-occlusive coil is detached from the core wire by electrolysis. More particularly, the electrical current applied to the core wire dissolves the stainless steel coil or joint that is exposed to blood and attached to the distal end of the core wire, thereby detaching the vaso-occlusive coil at the aneurysm site. The core wire and catheter can then be retracted, leaving the vaso-occlusive coil in the aneurysm.
While known electrolytically detachable systems and methods have been used effectively in the past, various aspects of known devices can be improved.
In accordance with one embodiment, an assembly includes an implantable device, a conductive deployment mechanism and an electrolytically detachable junction member between the deployment mechanism and the implantable device. The deployment mechanism is used to deliver to the implantable device to a desired location. The electrolytically detachable junction member includes a plurality of fine wires that extend between the implantable device and the conductive deployment mechanism so that when electrical current is applied to the fine wires through the conductive deployment mechanism, the fine wires are electrolyzed and detached from the implantable device.
In accordance with another embodiment, an assembly includes an implantable vaso-occlusive coil, a conductive deployment mechanism and an electrolytically detachable junction member. The deployment mechanism is used to deliver the vaso-occlusive coil to a desired location. The electrolytically detachable junction member includes a plurality of fine stainless steel wires that have a diameter of about 0.0005″ so that when electrical current is applied to the fine stainless steel wires through the conductive deployment mechanism, the fine stainless steel wires are electrolyzed and detached from the vaso-occlusive coil.
In accordance with a further alternative embodiment, an assembly includes an implantable vaso-occlusive coil, a conductive deployment and an electrolytically detachable junction member. The electrolytically detachable junction member includes a plurality of fine stainless steel wires having a diameter of about 0.0005″ and a length of about 0.01″. Each fine stainless steel wire is partially coated with non-conductive coating. A first, proximal portion of each wire is bare. A second portion adjacent the first portion is coated with the non-conductive coating. A third portion adjacent the second portion is bare. A fourth, distal portion adjacent the third portion is coated with the non-conductive coating. The deployment mechanism is used to deliver the vaso-occlusive coil to a desired location. When electrical current is applied to proximal end of the fine stainless steel wires through the conductive deployment mechanism, the wires are electrolyzed and detached from the vaso-occlusive coil.
Another embodiment is directed to a method of introducing an implantable device, such as a vaso-occlusive coil, into a subject. The method includes introducing an assembly that includes an implantable device, a conductive deployment mechanism and an electrolytically detachable member into the subject. The deployment mechanism is used to deliver the implantable device to a desired location. Electrical current is applied to the junction member, which includes a plurality of fine wires, through the conductive deployment mechanism. As a result, the fine wires are electrolyzed by application of the current and detached from the implantable device.
In various embodiments, junction member can include wires made of materials, such as stainless steel, that can be electrolyzed. The junction member can include different numbers of wires, e.g., about two to ten wires and larger numbers of wires, e.g. as many as 500 or more fine wires. All of the wires can have the same diameter or different diameters. For example, a junction member may include about 20 wires, and the diameter of some or all of the wires can be about 0.0005″ A cross-sectional surface area of the group of fine wires may be about 3.93×10−6 inch2. For a 0.010″ length detachment zone including about 20 fine wires, the cylindrical surface area for all of the fine wires can be about 3.14×10−4 inch2. The fine wires can extend freely between the deployment mechanism and the implantable device or they can be wound or braided. The fine wires can also be partially coated for connecting to the deployment mechanism and the implantable device. For example, proximal ends of the fine wires can be bare and connected by a conductive connection, such as solder or a conductive polymer, to the conductive deployment mechanism. This allows current to flow through the deployment mechanism and to the fine wires. Distal ends of the fine wires can be covered with a non-conductive coating and inserted into a non-conductive barrier member, such as a polymer barrier member, of the implantable device.
Referring now to the drawings in which like reference numbers represent corresponding parts throughout:
In the following description, reference is made to the accompanying drawings which form a part hereof, and which show by way of illustration specific embodiments in which the invention may be practiced. It is to be understood that other embodiments may be utilized as structural changes may be made without departing from the scope of the present invention.
Referring to
Referring to
As used in this specification, a “fine” wire 210 is defined as a wire having a small diameter, i.e., about 0.00001″ to about 0.0025″, for example, about 0.0005″. According to on embodiment, such fine wires are stainless steel wires. According to one embodiment, a cross sectional area of an individual fine wire 210 is about 7.85×10−10 inch2 to about 4.9×10−5 inch2 and a volume of a single wire may be about 7.85×10−13 to about 3.43×10−8 inch3. A length of a fine wire may be about 0.01″ to about 0.0007″ and a length of an etched area of a fine wire 210 can be, for example, about 0.001″ to about 0.100″. Fine wire 210 dimensions may vary depending on the length of the fine wire 210. For example, longer fine wires 210 may have a larger diameter. In one embodiment, a fine wire 210 having a length of about 0.01″ may have a diameter of about 0.0001″ to about 0.0005″ and a fine wire 210 having a length of about 0.007″ may have a diameter of about 0.0025″. This specification refers to fine stainless steel fine wires 210 having diameters ranging from about 0.00001″ to about 0.0025″ for ease of explanation, and it should be understood that the relative dimensions of the assembly components shown in the figures are not necessarily representative of actual devices since relative component sizes are adjusted for purposes of illustration (e.g., as shown in
With continuing reference to
Referring to
Proximal ends 211 of the fine wires 210 may contact the solder 310 as in the embodiment shown in
Referring to
Referring to
Referring again to
Additionally,
For example, in the embodiment shown in
Referring to
Referring to
Further, it should be understood that with respect to embodiments shown in
Referring to
In the illustrated embodiment, the fine wire 210 is intermittently or alternately coated. In the illustrated embodiment, a first portion 1410 of the fine wire 210 at the proximal end 211 of the wire 210 is bare or uncoated, a second portion 1420 adjacent to the first portion 1410 is coated with a non-conductive coating 1422, a third portion 1430 adjacent to the second portion 1420 is bare, and a fourth portion 1440 at the distal end 212 of the wire 210 is coated with a non-conductive coating 1442, which can be the same as or different than the non-conductive coating 1422 of the second portion 1420. The non-conductive coatings 1422 and 1442 can be, for example, a polymide polymer or Parylene.
In the illustrated embodiment, the first portion 1410 is bare and connected to the deployment mechanism 120 with solder 310 or another suitable conductive connection, to allow conduction of electrical current from the conductive deployment mechanism 120, through the fine wire 210 and to the implantable device 130. The non-conductive coatings 1422 and 1442 of the second and fourth portions 1420 and 1440 define a bare third portion 1430, which is a detachment point or zone. Thus, the fourth portion 1440 includes a non-conductive coating 1442 to define the detachment zone (as previously discussed) and to facilitate connection to the non-conductive polymer or glue 500 that is applied to the proximal end 131 of the implantable device 130. With this configuration, during use, the assembly is delivered to a treatment site, and the third portion 1430 is exposed to blood, which is conductive. Electrical current is applied to conductive deployment mechanism 120 and to the fine wire 210, thereby causing electrolysis and disintegration of the third portion 1430 and detachment of the implantable device 130 at the treatment site.
Further, the bare third portion 1430 may be shorter than other portions to define a particular detachment point or zone. The length of the first portion 1410 may be shorter depending on how much of the fine wire 210 is connected to the distal end 122 of the deployment mechanism 120. For example, what may be required is a short length of the bare first portion 1410, e.g., a first portion 1410 that is about 2 mm long, or about 20% of a length of a fine wire 210, to allow the conductive distal end 211 to be connected to the conductive deployment mechanism 120 via the conductive solder 310, weld 410 or polymer. Accordingly, it should be understood that different portions can have the same or similar length and different lengths as necessary.
Referring to
Additionally, referring to
A typical vaso-occlusive coil 1520 is formed of platinum wire having a diameter of about 0.001″ to about 0.005″. The primary helical shape has an inner diameter of about 0.003″ to about 0.009″, and the outer diameter of the primary shape is about 0.009″ to about 0.017″. According to one embodiment, the diameter of a stainless steel fine wire 210 is about 10-50% of the diameter of the platinum wire that is used to form the vaso-occlusive coil. Further, according to another embodiment, the diameter of each fine wire 210 is about 1% to about 10% of an inner diameter of a primary shape of a wound implantable vaso-occlusive coil. Thus, with a primary shape having an inner diameter of about 0.003″ to about 0.0009″, the diameter of a fine wire 210 may be about 0.00003″ to about 0.0009″. Further, according to a further embodiment, the diameter of each fine wire 210 is about 1% to about 5% of an outer diameter of a primary shape of a wound implantable vaso-occlusive coil. Thus, with a primary shape having an outer diameter of about 0.009″ to about 0.017″, the diameter of a fine wire 210 may be about 0.00009″ to about 0.0009″.
Referring to
As a result, in step 1920, and as shown in
Embodiments including fine wire 210 electrolytically detachable junction members 110 provide a number of improvements and advantages over known electrolytically detachable junction members. For example, with embodiments, the surface area of the junction member 110 is substantially increased relative to the surface area of known junction members as a result of the junction member 110 including multiple fine wires 120. Increasing junction member 110 surface areas advantageously results in reduced current densities on the junction member 110. Reduced current densities achieved with embodiments advantageously result in fewer detachment byproducts being formed and deposited and more efficient detachment processes. Further, increased surface areas achieved with embodiments allow the same or similar current densities to be maintained while increasing overall current per mass, which improves corrosion.
For example, a cylindrical surface area of a detachment zone of a known electrolytically detachable device is about 5.5×10−5 inch2, and the cylindrical surface area of a detachment zone of an electrolytically detachable junction member 110 including fine wires 210 constructed according to embodiments can be about 3.14×10−7 inch2 to about 1.75×10−5 inch2, e.g., with about 1 to about 500 fine wires 210 or more fine wires as necessary. As a further example, the current density on known electrolytically detachable junction members is about 2×104 mA/inch2, whereas with embodiments, the current density of the group of fine wires 120 is less than 2×104 mA/inch2, e.g., about 1×102 mA/inch2 to about 2×104 mA/inch2.
An additional improvement is that the plurality of fine wires 120 results in lower detachable junction 110 impedance, which advantageously allows for use of lower voltages. For example, the average impedance of known electrolytically detachable junction members is about 6 kOhm, and the voltage applied to a known junction member is about 6 Volts, In contrast, electrolytically detachable junction members 110 including fine wires 210 according to embodiments are capable of lower impedances and lower voltages. For example, fine wire 210 detachable junctions 110 constructed according to embodiments may have impedances less than 6 kOhm, e.g., as low as 1 kOhm, and voltages less than 6 volts, e.g., as low as 1 volt, when 1 mA of current is applied. The impedance and voltage may also vary depending on the junction 110 configuration, and the impedance may range from about 1 kOhm to about 10 kOhm, and the voltage may range from about 1 volt to about 10 volts when about 1 mA of current is applied.
Embodiments provide further improvements and advantages with these capabilities since lower voltages result in generation of less noise compared to known higher voltage devices. Further, with less variable and lower voltage conditions achieved with embodiments, changes in impedance that are reflected in voltage values are more pronounced and identifiable, thereby facilitating detection of detachment and reducing the likelihood detachment detection errors.
Further benefits that are achieved are improved strength and flexibility. The number of fine wires 120 can be selected to provide the desired strength (e.g., tensile strength) and flexibility. Embodiments provide additional support when the implantable device 130 is pushed and pulled through a catheter. Further, the fine wires 120 can be braided or wound to provide greater strength and additional support as necessary. Thus, embodiments advantageously provide detachable junctions or temporary connections that may be designed to accommodate different flexibility and tensile strength requirements while reducing current densities on the junction.
The implantable device 130 can also include radiopaque, physiologically compatible material. For instance, the material may be platinum, gold, tungsten, or alloys of these. Certain polymers are also suitable for use in the implants, either alone or in conjunction with metallic markers providing radiopacity. These materials are chosen so that the procedure of locating the implant within the vessel may be viewed using radiography. However, it is also contemplated that the implantable device may be made of various other biologically inert polymers or of carbon fiber.
Although particular embodiments have been shown and described, it should be understood that the above discussion is not intended to limit the scope of these embodiments. Various changes and modifications may be made without departing from the spirit and scope of embodiments.
For example, fine wires 210 having small diameters of about 0.00001″ to about 0.0025″ may have various lengths, cross-sectional areas, surface areas and volumes and may form cylindrical or other shape structures having various dimensions and volumes.
In the chart 2200, column 2202 represents a diameter of a single fine wire 210. In the illustrated embodiments, the fine wire 210 diameter is 0.00001″, 0.0005″ and 0.0025″. Column 2204 represents a length of a single fine wire 210. In the illustrated embodiments, the length of the 0.00001″ and 0.0005″ diameter fine wires 210 is 0.0141 , and the length of the 0.0025″ diameter fine wire 210 is 0.007″. Column 2206 represents a cylindrical area or surface area of a single fine wire 210, column 2208 represents a cross-sectional area of a single fine wire 210, and column 2210 represents a volume of a single fine wire 210. Column 2212 represents a number of fine wires 2212 that may be utilized to form a junction member 110. In the illustrated embodiments, one junction member 110 includes 500 fine wires, another junction member 110 includes 20 fine wires, and a further junction member 110 includes a single fine wire 210. Column 2214 represents a total cylindrical or surface area of a collection or group of fine wires 210, column 2216 represents a cross-sectional area of a collection of fine wires 210 and column 2218 represents a volume of the fine wire 210. Column 2220 represents current densities achieved with different embodiments.
The table 210 also indicates the range of values for different dimensions, areas and volumes, expressed as a ratio. Thus,
Further, persons skilled in the art will appreciate that electrolytically severable fine wire junctions described herein can be used in a wide variety of applications and assemblies, including treatment of aneurysms using vaso-occlusive coils and other devices. Accordingly, the description and figures illustrating vaso-occlusive coils are provided for purposes of explanation and illustration, not limitation.
Thus, embodiments of the present are intended to cover alternatives, modifications, and equivalents that fall within the scope of the following claims.
The present application claims the benefit under 35 U.S.C. §119 to U.S. Provisional Application No. 60/991,856, filed Dec. 3, 2007, the contents of which are incorporated herein by reference as though set forth in full.
Number | Date | Country | |
---|---|---|---|
60991856 | Dec 2007 | US |